June 28, 2012
The pharmaceutical industry's recent emphasis on quality over quantity is working, as evidenced by a lower number of early-phase projects and fewer Phase III projects being terminated, combined with an increase in regulatory approvals, says a new report.
July 21, 2011
A lack of evidence linking diagnostic tests to health outcomes is hindering the growth of personalised medicines in the US, according to a new study.
May 31, 2011
The UK's Technology Strategy Board and Medical Research Council (MRC) are to jointly invest over £3.7 million in seven major project which, they say, will help place the UK at the forefront of developments into personalised medicine.
PharmaTimes 2013 Copyright | RSS Feed Subscriptions Website by DCSL Software